Related Experiment Video
Updated: Jul 1, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Diabetes and Coronary Intervention: Special Considerations for Antithrombotic Therapy
R. Scott Wright1, Gregory W. Barsness
1*Mayo Medical School, Division of Cardiology and The Mayo Physician Alliance for Clinical Trials, Mayo Clinic and Foundation, Stabile 5, 150 Third Street SW, Rochester, MN 55902, USA. wright.scott@mayo.edu
Abstract:
Diabetes mellitus is an increasing problem in the Western world and is associated with a more advanced state of coronary artery disease than that observed in non-diabetic patients. Diabetes mellitus is a prothrombotic state and poses some unique challenges to the interventional cardiologist. The development of more potent antithrombotic therapies has improved the safety and effectiveness of percutaneous coronary intervention (PCI), particularly in high-risk groups such as diabetic patients. This article summarizes the available data on the use of heparins (unfractionated and low molecular weight), intravenous glycoprotein IIb/IIIa blockers, and oral antiplatelet agents in diabetic patients undergoing PCI.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Angina IV: Management
Atherosclerosis III: Management
Peripheral Artery Disease III: Interprofessional Care

